Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katharina Belz"'
Publikováno v:
Cell Death & Differentiation. 22:1946-1956
Polo-like kinase 1 (PLK1) is frequently overexpressed in cancer, which correlates with poor prognosis. Therefore, we investigated PLK1 as therapeutic target using rhabdomyosarcoma (RMS) as a model. Here, we identify a novel synthetic lethal interacti
Publikováno v:
Oncogene. 34:4032-4043
Evasion of apoptosis in pediatric acute lymphoblastic leukemia (ALL) is linked to aberrant expression of inhibitor of apoptosis (IAP) proteins and dysregulated redox homeostasis, rendering leukemic cells vulnerable to redox-targeting therapies. Here
Publikováno v:
Cancer letters. 355(2)
Therapeutic targeting of inhibitor of apoptosis (IAP) proteins by small-molecule inhibitors such as Smac mimetic is considered as a promising anticancer strategy to elicit apoptosis. Recent advances have renewed the interest in exploiting the antileu
Autor:
S. Wehner, Thomas Klingebiel, Halvard Bonig, Hannah Schoeneberger, Simone Fulda, Katharina Belz, Andreas Weigert, Iduna Fichtner
Publikováno v:
Blood. 124(2)
Apoptosis resistance contributes to poor outcome in pediatric acute lymphoblastic leukemia (ALL). Here, we identify a novel synergistic combination of Smac mimetic BV6 and glucocorticoids (GCs) (ie, dexamethasone, prednisolone) to trigger apoptosis i
Publikováno v:
Cell Death & Disease
Evasion of apoptosis, for example, by inhibitor of apoptosis (IAP) proteins, contributes to treatment resistance and poor outcome in acute myeloid leukemia (AML). Here we identify a novel synergistic interaction between the small-molecule second mito